# Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis

> **NCT01449877** · PHASE3 · COMPLETED · sponsor: **University of Campinas, Brazil** · enrollment: 141 (actual)

## Conditions studied

- Ocular Toxoplasmosis

## Interventions

- **DRUG:** Trimethoprim-Sulfamethoxazole

## Key facts

- **NCT ID:** NCT01449877
- **Lead sponsor:** University of Campinas, Brazil
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 141 (ACTUAL)
- **Last updated:** 2016-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01449877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01449877, "Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01449877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*